Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Absolute Bioavailability, Pharmacokinetics, Excretion, and Metabolism of [14C]Acp-196 (Acalabrutinib) in Healthy Subjects

NCT04898101 is registered in ClinicalTrials.gov with Acerta Pharma BV as lead sponsor.

NCT NCT04898101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04898101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Absolute Bioavailability, Pharmacokinetics, Excretion, and Metabolism of [14C]Acp-196 (Acalabrutinib) in Healthy Subjects
Lead sponsor
Acerta Pharma BV
Phase
Phase 1
Overall status
Completed
Start date
March 3, 2016
Completion date
April 13, 2016
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers